Blog
New

Posttraumatic Stress Disorder Associated With Reduced Brain Volume

Investigators compare brain changes in PTSD because they could be associated with the comorbid major depressive disorder rather than the diagnosis of PTSD.

Read More
New

Disease Specific Variables Effecting Quality of Life in First-Episode Psychosis

Quality of life has emerged as an important factor for research because it may be valuable to measure treatment outcomes.

Read More
New

Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome

This finding suggests that clinicians should monitor anxiety among individuals with testosterone deficiency and XXY.

Read More
New

Pharmacologic Treatment of First-Episode Psychosis: Advances in Research

The NAVIGATE program shows great promise toward optimizing pharmacologic management of psychosis.

Read More
New

Does Bipolar I Disorder Effect the Course of Conduct/Antisocial Personality Disorders in Adolescents?

Adolescents with bipolar I disorder whose symptoms are in remission are significantly less likely to experience conduct disorder or antisocial personality disorder.

Read More
New

Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice

Meditation techniques have an ever-growing evidence base to support their use and have become increasingly accepted in Western medicine as helpful adjuncts to other therapies.

Read More
New

Terms Used for Addiction May Be Associated With Explicit, Implicit Bias

Stigmatizing terms used to describe individuals who have a substance addiction, including “addict,” alcoholic,” and “substance abuser,” may be associated with negative explicit and implicit biases and should be replaced with positive terms that still describe the conditions accurately.

Read More
New

Parity Legislature Associated With Financial Protections for Youths With Mental Illness

MHPAEA enforcement was positively associated with lower spending for mental illness treatment among those with parity-associated policies.

Read More
News

How ketamine is revolutionizing the way we treat depression

How ketamine is revolutionizing the way we treat depression

Read More
News
News

Miracle Network Keith-Ablow, MD

Miracle Network Keith-Ablow, MD

Read More
News

Chairman The Classics of Psychiatry & Behavioral Sciences Library January 2018 

Chairman The Classics of Psychiatry & Behavioral Sciences Library January 2018 

Read More
News

Linked IN

Keith Ablow on On of the Linked in Pages

Read More
New

Atypical Symptom Presentations in Pediatric OCD

Unexpected presentations of OCD can put children at risk of receiving diagnoses or treatments that do not address their underlying obsessions.

Read More
New

Marijuana’s Uncertain Status: Closing the Gap Between State and Federal Policies

Senator Elizabeth Warren introduced a bipartisan bill in June 2018 (S.3032) that would exempt most marijuana-related activities from the Controlled Substances Act when they are allowed under state or tribal law.

Read More